18 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
17 Jan 19
Zafgen Announces Positive Results for Second Cohort
7:30am
for new options and innovative mechanisms to address this complex disease and growing epidemic,” said Jeffrey Hatfield, Chief Executive Officer, Zafgen
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
12 Jan 15
Other Events
12:00am
are innovative, as they represent an exceptional level of success in the pharmaceutical treatment of HIAO, and are very encouraging for our field, as well
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
are well positioned to address complex rare diseases where patients are in need of innovative treatments.”
Chondrial Therapeutics’ lead asset,CTI
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
attractive and innovative clinical stage programs for the treatment of type 2 diabetes in the industry,” said Brian McVeigh, Chief Business Officer, Zafgen
DEFA14A
EX-99.1
LRMR
Larimar Therapeutics Inc
18 Dec 19
Additional proxy soliciting materials
8:11am
are well positioned to address complex rare diseases where patients are in need of innovative treatments.”
Chondrial Therapeutics’ lead asset,CTI
8-K
EX-99.2
r9evm x871q
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.2
7r8iekvxhifu
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.1
6fb6r
13 Jan 20
Regulation FD Disclosure
7:17am
DEFA14A
EX-99.1
wnbaopkprea
13 Jan 20
Additional proxy soliciting materials
7:15am
DEFA14A
mc27wyq1a1asu95p8
18 Dec 19
Additional proxy soliciting materials
4:31pm
8-K
0bpmncy 4xvmq
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
PRER14A
fqki8nfuj oy
10 Apr 20
Preliminary revised proxy
4:38pm
DEFM14A
sfbys0ptqtyn55651
29 Apr 20
Proxy related to merger
3:20pm
PREM14A
td7qg0ee3qq4
6 Mar 20
Preliminary proxy related to merger
5:32pm
- Prev
- 1
- Next